Biogen's Stock Could More Than Quadruple in Value in 5 Years

Biogen's Stock Could More Than Quadruple in Value in 5 Years

Source: 
Motley Fool
snippet: 

Biogen's (NASDAQ: BIIB) stock caught fire yesterday. Although the biotech posted stellar third-quarter results that surpassed analysts' expectations ahead of the opening bell on Tuesday, the real market-mover proved to be the unexpected news about its Alzheimer's disease candidate, aducanumab.